Study identifier:SH-QBE-0041
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
A multicenter, randomized, double-blind, safety and efficacy study of H 199/18 with amoxicillin plus clarithromycin compared to H 199/18 with clarithromycin for the eradication of Helicobacter pylori in subjects with active duodenal ulcer or history of duodenal ulcer disease
gastrointestinal diseases
N/A
-
-
-
-
Interventional
-
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Nov 2013 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|